Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Neurath

Showing results (141-150 of 775) with videos related to

Pageof 78
Sort By:
Nature Reviews. Immunology|April 17, 2020
COVID-19: risk for cytokine targeting in chronic inflammatory diseases?Georg Schett, Michael Sticherling, Markus F Neurath
Best Practice & Research. Clinical Gastroenterology|September 16, 2008
Virtual histologyRalf Kiesslich, Martin Goetz, Markus F Neurath
Gut|July 31, 2012
Mucosal healing in inflammatory bowel diseases: a systematic reviewMarkus F Neurath, Simon P L Travis
Inflammatory Bowel Diseases|July 27, 2005
Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptorsChristoph Becker, Stefan Wirtz, Markus F Neurath
Seminars in Immunopathology|November 2, 2019
Resolution of acute intestinal graft-versus-host diseaseSindhu Thiagarajan, Markus F Neurath, Kai Hildner
Inflammatory Bowel Diseases|February 26, 2013
Targeted inhibition of Vav1 activity does not favour development of colitis-associated colon cancerStefanie Zenker, Markus F Neurath, Imke Atreya
Expert Review of Gastroenterology & Hepatology|August 22, 2023
A spotlight on intestinal permeability and inflammatory bowel diseasesTimo Rath, Raja Atreya, Markus F Neurath
Visceral Medicine|October 1, 2020
Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?Abdullah Abdullah, Markus F Neurath, Raja Atreya
ILAR Journal|September 2, 2015
The Intestinal Microbiota in Inflammatory Bowel DiseaseChristoph Becker, Markus F Neurath, Stefan Wirtz
Visceral Medicine|June 15, 2017
Professor Joachim Mössner Retires as Editor-in-ChiefErnst Klar, Georg Kähler, Markus F Neurath
Pageof 78

Showing results (141-150 of 775) with videos related to

Sort By:
Pageof 78
Nature Reviews. Immunology|April 17, 2020
COVID-19: risk for cytokine targeting in chronic inflammatory diseases?Georg Schett, Michael Sticherling, Markus F Neurath
Best Practice & Research. Clinical Gastroenterology|September 16, 2008
Virtual histologyRalf Kiesslich, Martin Goetz, Markus F Neurath
Gut|July 31, 2012
Mucosal healing in inflammatory bowel diseases: a systematic reviewMarkus F Neurath, Simon P L Travis
Inflammatory Bowel Diseases|July 27, 2005
Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptorsChristoph Becker, Stefan Wirtz, Markus F Neurath
Seminars in Immunopathology|November 2, 2019
Resolution of acute intestinal graft-versus-host diseaseSindhu Thiagarajan, Markus F Neurath, Kai Hildner
Inflammatory Bowel Diseases|February 26, 2013
Targeted inhibition of Vav1 activity does not favour development of colitis-associated colon cancerStefanie Zenker, Markus F Neurath, Imke Atreya
Expert Review of Gastroenterology & Hepatology|August 22, 2023
A spotlight on intestinal permeability and inflammatory bowel diseasesTimo Rath, Raja Atreya, Markus F Neurath
Visceral Medicine|October 1, 2020
Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?Abdullah Abdullah, Markus F Neurath, Raja Atreya
ILAR Journal|September 2, 2015
The Intestinal Microbiota in Inflammatory Bowel DiseaseChristoph Becker, Markus F Neurath, Stefan Wirtz
Visceral Medicine|June 15, 2017
Professor Joachim Mössner Retires as Editor-in-ChiefErnst Klar, Georg Kähler, Markus F Neurath
Pageof 78